Skip to main content
NCBI home page
Protein Science : A Publication of the Protein Society logoLink to Protein Science : A Publication of the Protein Society
. 1999 Jun;8(6):1332–1341. doi: 10.1110/ps.8.6.1332

A novel recombinant single-chain hepatitis C virus NS3-NS4A protein with improved helicase activity.

A Y Howe 1, R Chase 1, S S Taremi 1, C Risano 1, B Beyer 1, B Malcolm 1, J Y Lau 1
PMCID: PMC2144360  PMID: 10386883

Abstract

Hepatitis C virus (HCV) nonstructural protein 3 (NS3) has been shown to possess protease and helicase activities and has also been demonstrated to spontaneously associate with nonstructural protein NS4A (NS4A) to form a stable complex. Previous attempts to produce the NS3/NS4A complex in recombinant baculovirus resulted in a protein complex that aggregated and precipitated in the absence of nonionic detergent and high salt. A single-chain form of the NS3/NS4A complex (His-NS4A21-32-GSGS-NS3-631) was constructed in which the NS4A core peptide is fused to the N-terminus of the NS3 protease domain as previously described (Taremi et al., 1998). This protein contains a histidine tagged NS4A peptide (a.a. 21-32) fused to the full-length NS3 (a.a. 3-631) through a flexible tetra amino acid linker. The recombinant protein was expressed to high levels in Escherichia coli, purified to homogeneity, and examined for NTPase, nucleic acid unwinding, and proteolytic activities. The single-chain recombinant NS3-NS4A protein possesses physiological properties equivalent to those of the NS3/NS4A complex except that this novel construct is stable, soluble and sixfold to sevenfold more active in unwinding duplex RNA. Comparison of the helicase activity of the single-chain recombinant NS3-NS4A with that of the full-length NS3 (without NS4A) and that of the helicase domain alone suggested that the presence of the protease domain and at least the NS4A core peptide are required for optimal unwinding activity.

Full Text

The Full Text of this article is available as a PDF (581.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altenschmidt U., Kahl R., Moritz D., Schnierle B. S., Gerstmayer B., Wels W., Groner B. Cytolysis of tumor cells expressing the Neu/erbB-2, erbB-3, and erbB-4 receptors by genetically targeted naive T lymphocytes. Clin Cancer Res. 1996 Jun;2(6):1001–1008. [PubMed] [Google Scholar]
  2. Alter H. J., Purcell R. H., Shih J. W., Melpolder J. C., Houghton M., Choo Q. L., Kuo G. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med. 1989 Nov 30;321(22):1494–1500. doi: 10.1056/NEJM198911303212202. [DOI] [PubMed] [Google Scholar]
  3. Alter M. J., Mast E. E. The epidemiology of viral hepatitis in the United States. Gastroenterol Clin North Am. 1994 Sep;23(3):437–455. [PubMed] [Google Scholar]
  4. Bianchi E., Urbani A., Biasiol G., Brunetti M., Pessi A., De Francesco R., Steinkühler C. Complex formation between the hepatitis C virus serine protease and a synthetic NS4A cofactor peptide. Biochemistry. 1997 Jun 24;36(25):7890–7897. doi: 10.1021/bi9631475. [DOI] [PubMed] [Google Scholar]
  5. Choo Q. L., Kuo G., Weiner A. J., Overby L. R., Bradley D. W., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989 Apr 21;244(4902):359–362. doi: 10.1126/science.2523562. [DOI] [PubMed] [Google Scholar]
  6. Failla C., Tomei L., De Francesco R. An amino-terminal domain of the hepatitis C virus NS3 protease is essential for interaction with NS4A. J Virol. 1995 Mar;69(3):1769–1777. doi: 10.1128/jvi.69.3.1769-1777.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fernández A., Guo H. S., Sáenz P., Simón-Buela L., Gómez de Cedrón M., García J. A. The motif V of plum pox potyvirus CI RNA helicase is involved in NTP hydrolysis and is essential for virus RNA replication. Nucleic Acids Res. 1997 Nov 15;25(22):4474–4480. doi: 10.1093/nar/25.22.4474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Finney H. M., Lawson A. D., Bebbington C. R., Weir A. N. Chimeric receptors providing both primary and costimulatory signaling in T cells from a single gene product. J Immunol. 1998 Sep 15;161(6):2791–2797. [PubMed] [Google Scholar]
  9. Gallinari P., Brennan D., Nardi C., Brunetti M., Tomei L., Steinkühler C., De Francesco R. Multiple enzymatic activities associated with recombinant NS3 protein of hepatitis C virus. J Virol. 1998 Aug;72(8):6758–6769. doi: 10.1128/jvi.72.8.6758-6769.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gorbalenya A. E., Koonin E. V., Donchenko A. P., Blinov V. M. A novel superfamily of nucleoside triphosphate-binding motif containing proteins which are probably involved in duplex unwinding in DNA and RNA replication and recombination. FEBS Lett. 1988 Aug 1;235(1-2):16–24. doi: 10.1016/0014-5793(88)81226-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Grakoui A., Wychowski C., Lin C., Feinstone S. M., Rice C. M. Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol. 1993 Mar;67(3):1385–1395. doi: 10.1128/jvi.67.3.1385-1395.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gross C. H., Shuman S. The nucleoside triphosphatase and helicase activities of vaccinia virus NPH-II are essential for virus replication. J Virol. 1998 Jun;72(6):4729–4736. doi: 10.1128/jvi.72.6.4729-4736.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gross C. H., Shuman S. Vaccinia virions lacking the RNA helicase nucleoside triphosphate phosphohydrolase II are defective in early transcription. J Virol. 1996 Dec;70(12):8549–8557. doi: 10.1128/jvi.70.12.8549-8557.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gwack Y., Kim D. W., Han J. H., Choe J. Characterization of RNA binding activity and RNA helicase activity of the hepatitis C virus NS3 protein. Biochem Biophys Res Commun. 1996 Aug 14;225(2):654–659. doi: 10.1006/bbrc.1996.1225. [DOI] [PubMed] [Google Scholar]
  15. Gwack Y., Kim D. W., Han J. H., Choe J. DNA helicase activity of the hepatitis C virus nonstructural protein 3. Eur J Biochem. 1997 Nov 15;250(1):47–54. doi: 10.1111/j.1432-1033.1997.00047.x. [DOI] [PubMed] [Google Scholar]
  16. Heinz F. X. Comparative molecular biology of flaviviruses and hepatitis C virus. Arch Virol Suppl. 1992;4:163–171. doi: 10.1007/978-3-7091-5633-9_35. [DOI] [PubMed] [Google Scholar]
  17. Jin L., Peterson D. L. Expression, isolation, and characterization of the hepatitis C virus ATPase/RNA helicase. Arch Biochem Biophys. 1995 Oct 20;323(1):47–53. doi: 10.1006/abbi.1995.0008. [DOI] [PubMed] [Google Scholar]
  18. Kim D. W., Gwack Y., Han J. H., Choe J. C-terminal domain of the hepatitis C virus NS3 protein contains an RNA helicase activity. Biochem Biophys Res Commun. 1995 Oct 4;215(1):160–166. doi: 10.1006/bbrc.1995.2447. [DOI] [PubMed] [Google Scholar]
  19. Kim D. W., Gwack Y., Han J. H., Choe J. Towards defining a minimal functional domain for NTPase and RNA helicase activities of the hepatitis C virus NS3 protein. Virus Res. 1997 May;49(1):17–25. doi: 10.1016/s0168-1702(97)01452-4. [DOI] [PubMed] [Google Scholar]
  20. Kim D. W., Kim J., Gwack Y., Han J. H., Choe J. Mutational analysis of the hepatitis C virus RNA helicase. J Virol. 1997 Dec;71(12):9400–9409. doi: 10.1128/jvi.71.12.9400-9409.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kim J. L., Morgenstern K. A., Lin C., Fox T., Dwyer M. D., Landro J. A., Chambers S. P., Markland W., Lepre C. A., O'Malley E. T. Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide. Cell. 1996 Oct 18;87(2):343–355. doi: 10.1016/s0092-8674(00)81351-3. [DOI] [PubMed] [Google Scholar]
  22. Koch J. O., Lohmann V., Herian U., Bartenschlager R. In vitro studies on the activation of the hepatitis C virus NS3 proteinase by the NS4A cofactor. Virology. 1996 Jul 1;221(1):54–66. doi: 10.1006/viro.1996.0352. [DOI] [PubMed] [Google Scholar]
  23. Koonin E. V., Dolja V. V. Evolution and taxonomy of positive-strand RNA viruses: implications of comparative analysis of amino acid sequences. Crit Rev Biochem Mol Biol. 1993;28(5):375–430. doi: 10.3109/10409239309078440. [DOI] [PubMed] [Google Scholar]
  24. Korolev S., Yao N., Lohman T. M., Weber P. C., Waksman G. Comparisons between the structures of HCV and Rep helicases reveal structural similarities between SF1 and SF2 super-families of helicases. Protein Sci. 1998 Mar;7(3):605–610. doi: 10.1002/pro.5560070309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kuo G., Choo Q. L., Alter H. J., Gitnick G. L., Redeker A. G., Purcell R. H., Miyamura T., Dienstag J. L., Alter M. J., Stevens C. E. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 1989 Apr 21;244(4902):362–364. doi: 10.1126/science.2496467. [DOI] [PubMed] [Google Scholar]
  26. Lama J., Paul A. V., Harris K. S., Wimmer E. Properties of purified recombinant poliovirus protein 3aB as substrate for viral proteinases and as co-factor for RNA polymerase 3Dpol. J Biol Chem. 1994 Jan 7;269(1):66–70. [PubMed] [Google Scholar]
  27. Landro J. A., Raybuck S. A., Luong Y. P., O'Malley E. T., Harbeson S. L., Morgenstern K. A., Rao G., Livingston D. J. Mechanistic role of an NS4A peptide cofactor with the truncated NS3 protease of hepatitis C virus: elucidation of the NS4A stimulatory effect via kinetic analysis and inhibitor mapping. Biochemistry. 1997 Aug 5;36(31):9340–9348. doi: 10.1021/bi963054n. [DOI] [PubMed] [Google Scholar]
  28. Lin C., Rice C. M. The hepatitis C virus NS3 serine proteinase and NS4A cofactor: establishment of a cell-free trans-processing assay. Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7622–7626. doi: 10.1073/pnas.92.17.7622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Lohmann V., Koch J. O., Bartenschlager R. Processing pathways of the hepatitis C virus proteins. J Hepatol. 1996;24(2 Suppl):11–19. [PubMed] [Google Scholar]
  30. Mizokami M., Ohba K. Molecular classification of hepatitis C virus. Gastroenterol Jpn. 1993 May;28 (Suppl 5):42–44. doi: 10.1007/BF02989203. [DOI] [PubMed] [Google Scholar]
  31. Morgenstern K. A., Landro J. A., Hsiao K., Lin C., Gu Y., Su M. S., Thomson J. A. Polynucleotide modulation of the protease, nucleoside triphosphatase, and helicase activities of a hepatitis C virus NS3-NS4A complex isolated from transfected COS cells. J Virol. 1997 May;71(5):3767–3775. doi: 10.1128/jvi.71.5.3767-3775.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Mousli M., Goyffon M., Billiald P. Production and characterization of a bivalent single chain Fv/alkaline phosphatase conjugate specific for the hemocyanin of the scorpion Androctonus australis. Biochim Biophys Acta. 1998 Oct 23;1425(2):348–360. doi: 10.1016/s0304-4165(98)00090-7. [DOI] [PubMed] [Google Scholar]
  33. Muramatsu S., Ishido S., Fujita T., Itoh M., Hotta H. Nuclear localization of the NS3 protein of hepatitis C virus and factors affecting the localization. J Virol. 1997 Jul;71(7):4954–4961. doi: 10.1128/jvi.71.7.4954-4961.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Ohba K., Mizokami M., Lau J. Y., Orito E., Ikeo K., Gojobori T. Evolutionary relationship of hepatitis C, pesti-, flavi-, plantviruses, and newly discovered GB hepatitis agents. FEBS Lett. 1996 Jan 15;378(3):232–234. doi: 10.1016/0014-5793(95)01441-1. [DOI] [PubMed] [Google Scholar]
  35. Reichard O., Norkrans G., Frydén A., Braconier J. H., Sönnerborg A., Weiland O. Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group. Lancet. 1998 Jan 10;351(9096):83–87. doi: 10.1016/s0140-6736(97)06088-1. [DOI] [PubMed] [Google Scholar]
  36. Sali D. L., Ingram R., Wendel M., Gupta D., McNemar C., Tsarbopoulos A., Chen J. W., Hong Z., Chase R., Risano C. Serine protease of hepatitis C virus expressed in insect cells as the NS3/4A complex. Biochemistry. 1998 Mar 10;37(10):3392–3401. doi: 10.1021/bi972010r. [DOI] [PubMed] [Google Scholar]
  37. Shimizu Y., Yamaji K., Masuho Y., Yokota T., Inoue H., Sudo K., Satoh S., Shimotohno K. Identification of the sequence on NS4A required for enhanced cleavage of the NS5A/5B site by hepatitis C virus NS3 protease. J Virol. 1996 Jan;70(1):127–132. doi: 10.1128/jvi.70.1.127-132.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Shimotohno K., Tanji Y., Hirowatari Y., Komoda Y., Kato N., Hijikata M. Processing of the hepatitis C virus precursor protein. J Hepatol. 1995;22(1 Suppl):87–92. [PubMed] [Google Scholar]
  39. Simmonds P. Virology of hepatitis C virus. Clin Ther. 1996;18 (Suppl B):9–36. doi: 10.1016/S0149-2918(96)80193-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Suzich J. A., Tamura J. K., Palmer-Hill F., Warrener P., Grakoui A., Rice C. M., Feinstone S. M., Collett M. S. Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes. J Virol. 1993 Oct;67(10):6152–6158. doi: 10.1128/jvi.67.10.6152-6158.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Tai C. L., Chi W. K., Chen D. S., Hwang L. H. The helicase activity associated with hepatitis C virus nonstructural protein 3 (NS3). J Virol. 1996 Dec;70(12):8477–8484. doi: 10.1128/jvi.70.12.8477-8484.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Takamizawa A., Mori C., Fuke I., Manabe S., Murakami S., Fujita J., Onishi E., Andoh T., Yoshida I., Okayama H. Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol. 1991 Mar;65(3):1105–1113. doi: 10.1128/jvi.65.3.1105-1113.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Tanji Y., Hijikata M., Hirowatari Y., Shimotohno K. Hepatitis C virus polyprotein processing: kinetics and mutagenic analysis of serine proteinase-dependent cleavage. J Virol. 1994 Dec;68(12):8418–8422. doi: 10.1128/jvi.68.12.8418-8422.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Tanji Y., Hijikata M., Satoh S., Kaneko T., Shimotohno K. Hepatitis C virus-encoded nonstructural protein NS4A has versatile functions in viral protein processing. J Virol. 1995 Mar;69(3):1575–1581. doi: 10.1128/jvi.69.3.1575-1581.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Tomei L., Failla C., Vitale R. L., Bianchi E., De Francesco R. A central hydrophobic domain of the hepatitis C virus NS4A protein is necessary and sufficient for the activation of the NS3 protease. J Gen Virol. 1996 May;77(Pt 5):1065–1070. doi: 10.1099/0022-1317-77-5-1065. [DOI] [PubMed] [Google Scholar]
  46. Wimmer E., Hellen C. U., Cao X. Genetics of poliovirus. Annu Rev Genet. 1993;27:353–436. doi: 10.1146/annurev.ge.27.120193.002033. [DOI] [PubMed] [Google Scholar]
  47. Xiang W., Harris K. S., Alexander L., Wimmer E. Interaction between the 5'-terminal cloverleaf and 3AB/3CDpro of poliovirus is essential for RNA replication. J Virol. 1995 Jun;69(6):3658–3667. doi: 10.1128/jvi.69.6.3658-3667.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Yan Y., Li Y., Munshi S., Sardana V., Cole J. L., Sardana M., Steinkuehler C., Tomei L., De Francesco R., Kuo L. C. Complex of NS3 protease and NS4A peptide of BK strain hepatitis C virus: a 2.2 A resolution structure in a hexagonal crystal form. Protein Sci. 1998 Apr;7(4):837–847. doi: 10.1002/pro.5560070402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Yao N., Hesson T., Cable M., Hong Z., Kwong A. D., Le H. V., Weber P. C. Structure of the hepatitis C virus RNA helicase domain. Nat Struct Biol. 1997 Jun;4(6):463–467. doi: 10.1038/nsb0697-463. [DOI] [PubMed] [Google Scholar]

Articles from Protein Science : A Publication of the Protein Society are provided here courtesy of The Protein Society

RESOURCES